Anlotinib: Phase II data

Data from 154 evaluable patients with STS in an open-label, Chinese Phase II trial

Read the full 147 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE